Resource Type

Journal Article 6

Year

2022 1

2021 1

2020 2

2009 1

2008 1

Keywords

COVID-19 2

hypertension 2

Angiotensin-converting enzyme 1

Clinical characteristics 1

Coronavirus disease 2019 1

His-Purkinje pacing 1

Immune response 1

Inflammation 1

RAS inhibitor 1

SARS-CoV-2 1

Sprague 1

Treatment 1

Vaccine 1

administration 1

all-cause mortality 1

angiotensin 1

angiotensin II 1

angiotensin II receptor blocker 1

angiotensin-converting enzyme inhibitor 1

beta-elemene 1

open ︾

Search scope:

排序： Display mode:

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Frontiers of Medicine 2009, Volume 3, Issue 1,   Pages 36-40 doi: 10.1007/s11684-009-0020-y

Abstract: This study aims to investigate the influence of β-elemene on the secretion of angiotensin II (ANG II)and the expression of angiotensin receptor type 1 (AT1R) in hepatic stellate cells (HSCs)

Keywords： liver cirrhosis     beta-elemene     hepatic stellate cells     angiotensin II     receptor     angiotensin     type 1    

HTML PDF Collect

Effects of RNA interference targeting angiotensin 1a receptor on blood pressure and cardiac hypertrophy

ZHANG Jingqun, SUN Honglei, MA Yexin, WANG Daowen

Frontiers of Medicine 2008, Volume 2, Issue 1,   Pages 19-24 doi: 10.1007/s11684-008-0005-2

Abstract: The aim of this study is to investigate the effects of RNA interference (RNAi) targeting angiotensin

Keywords： therapy     Sprague     administration     cardiac hypertrophy     valsartan    

HTML PDF Collect

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID

Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Fei Zhou, Yeming Wang, Jiapei Yu, Luning Yang, Ke Xie, Zhisheng Huang, Lixue Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang

Frontiers of Medicine 2020, Volume 14, Issue 5,   Pages 601-612 doi: 10.1007/s11684-020-0800-y

Abstract: The possible effects of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockersOur findings confirm the lack of an association between chronic receipt of renin-angiotensin system antagonists

Keywords： COVID-19     SARS-CoV-2     hypertension     angiotensin-converting enzyme inhibitor     angiotensin II receptor blocker    

HTML PDF Collect

Renin--angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID

Frontiers of Medicine 2022, Volume 16, Issue 1,   Pages 102-110 doi: 10.1007/s11684-021-0850-9

Abstract: retrospectively enrolled from January 2020 to March 2020 to investigate the association between the use of renin–angiotensinAssociations between the use of RAS-I (angiotensin-converting enzyme inhibitor (ACEI) or angiotensin

Keywords： COVID-19     RAS inhibitor     hypertension     all-cause mortality    

HTML PDF Collect

Strategies and Advances in Combating COVID-19 in China Review

Wei Liu, Wei-Jie Guan, Nan-Shan Zhong

Engineering 2020, Volume 6, Issue 10,   Pages 1076-1084 doi: 10.1016/j.eng.2020.10.003

Abstract:

Coronavirus disease 2019 (COVID-19)—the third in a series of coronavirus infections—has caused a global public health event in the 21st century, resulting in substantial global morbidity and mortality. Building on its legacy of managing severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), China has played a key role in the scientific community by revealing the viral transmission routes and clinical characteristics of COVID-19 and developing novel therapeutic interventions and vaccines. Despite these rapid scientific and technological advances, uncertainties remain in tracing the original sources of infection, determining the routes of transmission and pathogenesis, and addressing the lack of targeted clinical management of COVID-19. Here, we summarize the major COVID-19 research advances in China in order to provide useful information for global pandemic control.

Keywords： Coronavirus disease 2019     Angiotensin-converting enzyme     Immune response     Inflammation     Clinical characteristics    

HTML PDF Collect

Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement

Frontiers of Medicine 2021, Volume 15, Issue 3,   Pages 416-437 doi: 10.1007/s11684-021-0852-7

Abstract: conduction abnormalities, further reduction in para-valvular aortic regurgitation along with therapy of angiotensin

Keywords： hypertrophy and fibrosis     myocardial force-velocity relationship     His-Purkinje pacing     renin-angiotensin    

HTML PDF Collect

Title Author Date Type Operation

Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate

Ling YANG, Rui ZHU, Qingjing ZHU, Dan DAN, Jin YE, Keshu XU, Xiaohua HOU

Journal Article

Effects of RNA interference targeting angiotensin 1a receptor on blood pressure and cardiac hypertrophy

ZHANG Jingqun, SUN Honglei, MA Yexin, WANG Daowen

Journal Article

Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID

Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Fei Zhou, Yeming Wang, Jiapei Yu, Luning Yang, Ke Xie, Zhisheng Huang, Lixue Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Frederick G. Hayden, Peter W. Horby, Bin Cao, Chen Wang

Journal Article

Renin--angiotensin system inhibitor is associated with the reduced risk of all-cause mortality in COVID

Journal Article

Strategies and Advances in Combating COVID-19 in China

Wei Liu, Wei-Jie Guan, Nan-Shan Zhong

Journal Article

Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement

Journal Article